Atlas Trials

Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"

Clinical trial NCT03209479 · COMPLETED

Trial details

NCT number
NCT03209479
Sponsor
Teva Takeda Pharma Ltd.
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2015-11-24
Primary completion
2024-03-31
Enrollment
1332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.